Listing #4252968 oncnursingnews.com

222
The FDA granted a priority review for a Biologics License Application (BLA) to bastilimab for the treatment of recurrent or metastatic cervical cancer. Cancer ...

Category

Website Performance

observedNavigationStartTs 1292823487163
totalCumulativeLayoutShift 0 Sec
observedFirstPaint 1.35 Sec
observedFirstPaintTs 1292824834863
observedFirstContentfulPaintAllFrames 1.35 Sec
observedCumulativeLayoutShift 0 Sec
observedTimeOrigin 0 Sec
maxPotentialFID 0.28 Sec
observedSpeedIndexTs 1292826404542
observedDomContentLoaded 0.34 Sec
observedLastVisualChange 6.45 Sec
observedTraceEnd 9.64 Sec
observedSpeedIndex 2.92 Sec
observedTotalCumulativeLayoutShift 0 Sec
observedFirstMeaningfulPaintTs 1292824834863
firstContentfulPaint 2.14 Sec
observedLargestContentfulPaint 1.35 Sec
observedDomContentLoadedTs 1292823831618
observedLastVisualChangeTs 1292829934163
observedFirstContentfulPaint 1.35 Sec
observedFirstVisualChangeTs 1292824818163
observedFirstVisualChange 1.33 Sec
interactive 7.73 Sec
observedLoad 7.05 Sec
observedTimeOriginTs 1292823487163
cumulativeLayoutShift 0 Sec
observedNavigationStart 0 Sec
observedLargestContentfulPaintAllFrames 1.35 Sec
observedFirstContentfulPaintAllFramesTs 1292824834863
observedLargestContentfulPaintAllFramesTs 1292824834863
speedIndex 3.98 Sec
firstMeaningfulPaint 2.3 Sec
observedFirstContentfulPaintTs 1292824834863
cumulativeLayoutShiftMainFrame 0 Sec
observedLoadTs 1292830539953
observedLargestContentfulPaintTs 1292824834863
observedTraceEndTs 1292833130101
observedFirstMeaningfulPaint 1.35 Sec
largestContentfulPaint 4.62 Sec
totalBlockingTime 1.22 Sec
observedCumulativeLayoutShiftMainFrame 0 Sec